Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191105045342N1Phase 3Completed
Phase 3, open-label trial of melatonin in sleep disorder (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoints: pain score, sleep quality and 1 more. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191105045342N1.